What is tamsulosin used for
Pro Research Analysisby 
Searched over 200M research papers
Therapeutic Uses of Tamsulosin: An Overview
Treatment of Benign Prostatic Hyperplasia (BPH)
Primary Use in BPH
Tamsulosin is primarily used to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). It is a third-generation selective α1A adrenoceptor-blocking agent that helps relax the smooth muscles in the prostate and bladder, thereby improving urine flow and reducing symptoms1 7. Clinical trials have shown that tamsulosin significantly increases maximal urine flow (Qmax) and improves symptom scores compared to placebo7.
Long-term Efficacy
Tamsulosin has demonstrated sustained efficacy for up to six years in patients with mild to severe LUTS associated with BPH. It is effective in elderly patients and those with diabetes mellitus, and it does not interfere with concomitant antihypertensive therapy7.
Off-Label Uses in Urology
Lower Urinary Tract Symptoms in Women
Although tamsulosin is primarily used for BPH, it has also been used off-label to treat LUTS in women. Several randomized controlled trials (RCTs) have shown that tamsulosin is effective in improving symptoms and quality of life in women with LUTS. However, the safety profile remains uncertain, necessitating further well-conducted trials3.
Ureteral Stones
Tamsulosin has been found to facilitate the passage of distal ureteral stones and relieve renal colic. A large multicenter, randomized, double-blind, placebo-controlled trial demonstrated that tamsulosin significantly increased the stone expulsion rate and reduced the time to expulsion and the need for analgesics compared to placebo. This benefit was particularly notable for stones larger than 5mm4.
Acute Urinary Retention (AUR)
Tamsulosin is also used to prevent acute urinary retention (AUR) in the perioperative period for patients undergoing surgical procedures. Studies have shown that tamsulosin significantly reduces the risk of postoperative AUR, thereby improving patient quality of life and satisfaction with treatment2.
Pharmacokinetics and Formulations
Modified-Release and Oral Controlled Absorption System
Tamsulosin is available in various formulations, including modified-release (MR) and oral controlled absorption system (OCAS). The MR formulation has nearly 100% oral bioavailability in the fasted state but is affected by food intake. In contrast, the OCAS formulation is food-independent and has been shown to have similar efficacy with fewer cardiovascular adverse effects9.
Safety and Adverse Effects
Common Adverse Effects
The most common adverse effects of tamsulosin include dizziness and abnormal ejaculation. Less frequently, patients may experience asthenia, postural hypotension, and palpitations. Importantly, tamsulosin has not been associated with clinically significant changes in blood pressure in clinical trials7.
Potential Link to Dementia
Recent studies have suggested a potential link between tamsulosin use and an increased risk of dementia in elderly patients. However, the evidence is not conclusive, and further clinical trials with larger sample sizes are needed to establish a definitive relationship6.
Conclusion
Tamsulosin is a versatile medication primarily used for the treatment of LUTS associated with BPH. Its off-label uses extend to treating LUTS in women, facilitating the passage of ureteral stones, and preventing AUR in the perioperative period. While generally well-tolerated, its safety profile, particularly concerning long-term use and potential links to dementia, warrants further investigation.
Sources and full results
Most relevant research papers on this topic
Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses
Tamsulosin is a potent, third-generation selective 1A adrenoceptor-blocking agent used to treat lower urinary tract symptoms and other genitourinary tract conditions in both men and women.
Systematic Review[Use of tamsulosin for a prevention of acute urinary retention in the perioperative period in patients undergoing to surgical procedures].
Tamsulosin significantly reduces the risk of postoperative acute urinary retention, improving patient quality of life and satisfaction from treatment.
Systematic ReviewTamsulosin for treatment of lower urinary tract symptoms in women: a systematic review and meta-analysis
Tamsulosin is an effective treatment for lower urinary tract symptoms in women, but its safety remains unknown.
Meta-AnalysisEfficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Tamsulosin significantly facilitates stone passage and relieves renal colic in patients with distal ureteral stones, with a superior expulsion rate for stones >5mm.
RCT
Large Human Trial
Highly CitedTamsulosin in urology: beyond benign prostatic hyperplasia
Tamsulosin shows potential for treating various urological conditions, beyond benign prostatic hyperplasia, but further research is needed.
Tamsulosin and Dementia in old age: Is there any relationship?
Tamsulosin use is associated with a higher incidence of dementia in elderly patients with Benign Prostatic Hyperplasia.
Systematic ReviewTamsulosin
Tamsulosin 0.4 mg once daily effectively treats lower urinary tract symptoms in patients with benign prostatic hyperplasia, offering advantages over other alpha(1)-adrenoceptor antagonists in single-daily dosing and low hypotensive effects.
Literature ReviewHighly CitedPreoperative Tamsulosin to Prevent Postoperative Urinary Retention: A Randomized Controlled Trial.
Preoperative tamsulosin administration is not effective in reducing the incidence of postoperative urinary retention in patients undergoing abdominal surgery.
RCTPharmacokinetics and Pharmacodynamics of Tamsulosin in its Modified-Release and Oral Controlled Absorption System Formulations
The oral controlled absorption system (OCAS) formulation of tamsulosin has the same treatment efficacy as the modified-release formulation, but may cause fewer cardiovascular adverse effects.
Very Rigorous JournalTamsulosin: an overview
Tamsulosin is the most widely used antagonist in treating benign prostatic hyperplasia, but future studies need to address the lack of adequate randomized, placebo-controlled studies.
Literature Review